Author:
Hassanein Tarek,Sims Karen D.,Bennett Michael,Gitlin Norman,Lawitz Eric,Nguyen Tuan,Webster Lynn,Younossi Zobair,Schwartz Howard,Thuluvath Paul J.,Zhou Helen,Rege Bhaskar,McPhee Fiona,Zhou Nannan,Wind-Rotolo Megan,Chung Ellen,Griffies Amber,Grasela Dennis M.,Gardiner David F.
Reference12 articles.
1. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt;Sievert;Liver Int,2011
2. Hepatitis C virus (HCV) infection in Africa: a review;Karoney;Pan Afr Med J,2013
3. Preclinical characterization of BMS-791325, an allosteric Inhibitor of hepatitis C virus NS5B polymerase;Lemm;Antimicrob Agents Chemother,2014
4. Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection;Everson;Gastroenterology,2014
5. Pre-existence, emergence, and persistence of HCV genotype 4 NS5A resistance variants from the phase 2b COMMAND-1 study: daclatasvir plus peginterferon-alfa /ribavirin in treatment-naïve patients [abstract];McPhee;J Hepatol,2013
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献